跳至主要内容
临床试验/NCT00304850
NCT00304850已完成2 期

Efficacy of a Polyamine-free Diet Associated or Not With Ketamine on Early and Late Hyperalgesia After Breast Cancer Surgery

University Hospital, Bordeaux5 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2006年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
160
试验地点
5
主要终点
Morphine requirement

研究概览

简要总结

After surgery, sensitization and hyperexcitability of central nervous system result in acute and long lasting postoperative pain. It has been shown that N-methyl-D-aspartate (NMDA) receptors antagonist (such as ketamine) prevent this adverse neuroplasticity and potentiate analgesic drugs efficacy. Polyamines (putrescine, spermidine, spermine) are essential components of cells functioning and are also known as allosteric modulators of NMDA receptors. In animal studies, polyamine-free diet has confirmed these antinociceptive properties. This research aims at evaluating anti hyperalgesic properties of polyamine-free diet in women operated on breast cancer versus kétamine

详细描述

This multicentric, single blind study will enrol 160 women (18-75 years old) operated on tumorectomy and adenectomy (T1, T2, T3, N0, N1, M0) for breast cancer. Patients will be randomly assigned in a 2x2 factorial plan : Group 1 = control (n = 40) ; group 2 = ketamine group administered during and 48 hours after a standardized anesthesia (n = 40) ; group 3 = polyamine-free diet, 1 week and 72 hours after surgery (n = 40) ; group 4 : ketamine + polyamine-free diet (n = 40).

The amount of morphine for the 24 first postoperative hours will be compared between each group as well as pain score, allodynia (Von Frey filaments) and hyperalgesia (algometer). Chronic pain occurrence (post-mastectomy pain syndrome) will be evaluated at 3 and 6 months using adequate questionnaire ( analgesic scale). Diet observance will be controlled preoperatively by a dosage of polyamines in circulating red cells blood.

Polyamines deprivation and ketamine ability to reduce postoperative pain will be compared (isobolographic method). Anti-hyperalgesic properties of ketamine have already been demonstrated in urologic, orthopaedic and abdominal surgery. In case of additive or synergistic effect of a polyamine deprivation such a strategic could be helpful to achieve better postoperative rehabilitation in reducing chronic pain after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Breast cancer (T1, T2, T3, N0, N1, M0)
  • Age : 18 - 75
  • left or right tumorectomy with complete lymphadenectomy
  • left or right complete mastectomy with complete lymphadenectomy
  • complete lymphadenectomy within one week following simple tumorectomy
  • informed consent signed

排除标准

  • inflammatory tumor requiring pre-operative radiotherapy
  • previous history of total mastectomy or partial contralateral mastectomy
  • chronic inflammatory disease treated by corticoids or NSAI
  • chronic analgesic treatment
  • anti-arrhythmic or anti-epileptic treatments
  • morphinic treatment during the 7 days before surgery
  • excessive alcohol consumption or addiction
  • ketamine or neomycin contra-indication
  • severe cardiovascular disease

研究组 & 干预措施

R+ / K+

Experimental

干预措施: polyamine-free diet (Behavioral)

R+ / K+

Experimental

干预措施: Ketamine or placebo (Drug)

R+ / K-

Experimental

干预措施: polyamine-free diet (Behavioral)

R+ / K-

Experimental

干预措施: Ketamine or placebo (Drug)

R- / K+

Experimental

干预措施: Ketamine or placebo (Drug)

R- /K-

Placebo Comparator

干预措施: Ketamine or placebo (Drug)

结局指标

主要结局

Morphine requirement

时间窗: for the 24 postoperative hours

次要结局

  • Pain intensity for the 4 days (and possibly at 7th day if the patient is still hospitalized) after surgery(4 days)
  • Allodynia measurements(inclusion, 1, 2, 4 and 7 ddays after surgery)
  • Hyperesthesia measurements(inclusion, 1, 2, 4 and 7 ddays after surgery)
  • Chronic pain incidence(3 and 6 months)
  • Late allodynia and/or hyperesthesia(6 months)
  • safety of treatment(Along each patient folow-up)

研究者

发起方
University Hospital, Bordeaux
申办方类型
Other

研究点 (5)

Loading locations...

相似试验